These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 21301403

  • 1. Combination hormone therapy tied to slight increase in breast cancer deaths.
    Mayo Clin Womens Healthsource; 2011 Mar; 15(3):3. PubMed ID: 21301403
    [No Abstract] [Full Text] [Related]

  • 2. Abbreviated hormone replacement therapy trial answers some questions, raises new ones. The Women's Health Initiative is no longer testing the most widely prescribed estrogen and progestin combination--but the study's job is far from over.
    Harv Womens Health Watch; 2002 Oct; 10(2):2-4. PubMed ID: 12393317
    [No Abstract] [Full Text] [Related]

  • 3. So far, victories are few as breast cancer patients sue Wyeth over hormone therapy.
    Twombly R.
    J Natl Cancer Inst; 2007 Dec 19; 99(24):1828-9, 1835. PubMed ID: 18073368
    [No Abstract] [Full Text] [Related]

  • 4. Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
    Langer RD.
    Am J Epidemiol; 2009 Mar 15; 169(6):784-5; author reply 785-6. PubMed ID: 19208722
    [No Abstract] [Full Text] [Related]

  • 5. [Hormone replacement therapy in menopause].
    Breckwoldt M.
    Dtsch Med Wochenschr; 2003 Feb 21; 128(8):400. PubMed ID: 12594630
    [No Abstract] [Full Text] [Related]

  • 6. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, Wang CY, Brunner RL, Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka BS, Women's Health Initiative Mammogram Density Study Investigators.
    J Natl Cancer Inst; 2005 Sep 21; 97(18):1366-76. PubMed ID: 16174858
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Women's Health Initiative: not over yet. The largest study of women's health has raised at least as many questions as it has answered. Stay tuned.
    Harv Womens Health Watch; 2006 May 21; 13(9):1-4. PubMed ID: 16696133
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Health symptom-free women do not need preventive hormone replacement therapy. The risks outweigh the benefits; a large trial prematurely interrupted in the USA].
    von Schoultz B.
    Lakartidningen; 2002 Aug 22; 99(34):3276-8. PubMed ID: 12362844
    [No Abstract] [Full Text] [Related]

  • 15. The estrogen and progestin dilemma: new advice, labeling guidelines.
    Bren L.
    FDA Consum; 2003 Aug 22; 37(2):10-1. PubMed ID: 12715763
    [No Abstract] [Full Text] [Related]

  • 16. Effects of percutaneous estradiol-oral progesterone versus oral conjugated equine estrogens-medroxyprogesterone acetate on breast cell proliferation and bcl-2 protein in healthy women.
    Murkes D, Conner P, Leifland K, Tani E, Beliard A, Lundström E, Söderqvist G.
    Fertil Steril; 2011 Mar 01; 95(3):1188-91. PubMed ID: 21067727
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease.
    American College of Obstetricians and Gynecologists Committee on Gynecologic Practice.
    Obstet Gynecol; 2008 Nov 01; 112(5):1189-92. PubMed ID: 18978127
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.